REFERENCE
Smith, R. D., & Mallath, M. K. (2019). History of the Growing Burden of Cancer in India: From Antiquity to the 21st Century. Journal of Global Oncology, (5), 115.
Martel, C. D., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020). Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. The Lancet Global Health, 8(2).
Cancer today. Retrieved from http://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394424.
Lemjabbar-Alaoui, H., Hassan, O. U. I., Yang, Y.-W., & Buchanan, P. (2015). Lung cancer: Biology and treatment options.
Vanhove, K., Graulus, G. J., Mesotten, L., Thomeer, M., Derveaux, E., Noben, J. P., Guedens, W., & Adriaensens, P. (2019). The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism. Frontiers in oncology, 9, 1215.
Anastasiou, D. (2016). Tumour microenvironment factors shaping the cancer metabolism landscape. British Journal of Cancer, 116(3), 277286.
Ahn, C. S., & Metallo, C. M. (2015). Mitochondria as biosynthetic factories for cancer proliferation. Cancer & metabolism, 3(1), 1.
Clinical significance of ras oncogene activation in human lung cancer. (1993). Lung Cancer, 8(5-6), 338.
Massarelli, E., & Papadimitrakopoulou, V. A. (2012). Phosphatidykinosital 3-Kinase and Mammalian Target of Rapamycin Pathway in NonSmall-Cell Lung Cancer. Journal of Thoracic Oncology, 7(12).
Semenza, G. L. (2009). Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene, 29(5), 625634.
Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. (1993). Lung Cancer, 10(1-2), 128129.
Takashima, A., & Faller, D. V. (2013). Targeting the RAS oncogene. Expert opinion on therapeutic targets, 17(5), 507531.
West, J. B. (2017). Physiological Effects of Chronic Hypoxia. New England Journal of Medicine, 376(20), 19651971.
Miller, D. M., Thomas, S. D., Islam, A., Muench, D., & Sedoris, K. (2012). c-Myc and cancer metabolism. Clinical cancer research: an official journal of the American Association for Cancer Research, 18(20), 55465553.
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015). MYC, Metabolism, and Cancer. Cancer discovery, 5(10), 10241039.
De Berardinis R. J. (2008). Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genetics in medicine: official journal of the American College of Medical Genetics, 10(11), 767777.
Department of Biotechnology, AKS University, Satna (MP) - India